Dr. Pavan Kumar Kavali, MD

Dr. Kavali practices at Missouri Baptist Medical Center in Saint Louis, Missouri, part of BJC Health.

Dr. Kavali's NPI, 1609192277, was assigned on April 7, 2010. Dr. Kavali graduated from Morehouse School of Medicine in 2010. Dr. Kavali holds Missouri license 2016025803.

Dr. Kavali's primary practice is Missouri Baptist Medical Center, at 3015 N Ballas Rd, Saint Louis, MO 63131 in St. Louis County. The practice phone is (314) 996-5000.

Dr. Kavali's primary practice is Missouri Baptist Medical Center in Saint Louis, Missouri, part of BJC Health. Dr. Kavali is also affiliated with Barnes-Jewish Hospital. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Kavali to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kavali practices, 6 sites in all. Vendor and product names are available with a free account.

Vascular and interventional radiology is Dr. Kavali's primary specialty in the NPI Registry, under taxonomy code 2085R0204X. Dr. Kavali is licensed in Missouri.

CMS data shows 222 Medicare services from Dr. Kavali across 6 procedure codes in 2024, for 165 Medicare patients. Medicare paid $8,306 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 165 Medicare patients who saw Dr. Kavali in 2024. The largest group is 65 to 74, with 69 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 21% are also on Medicaid. Their average risk score is 3.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kavali's median patient age at 70, with 47% women.

In 2024, Dr. Kavali wrote 22 Medicare Part D claims. 77% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $471 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Kavali for performance year 2024, reported as part of a group. Dr. Kavali accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 10 papers to Dr. Kavali, published from 2016 to 2025. 2018 was the busiest year, with 2. The most frequent topics are Thrombolytic Therapy and Venous Thrombosis. Dr. Kavali's most frequent co-authors are Olaguoke K. Akinwande, MD, Mahboob Alam, MD and Geoffrey Douglas Barnes, MD.

Dmand AI links Dr. Kavali to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Postthrombotic Syndrome, Rectal Diseases and Colorectal Neoplasms. Washington University School of Medicine sponsors the most, 2.

CMS Open Payments shows 298 general payments to Dr. Kavali from 18 drug and device companies from 2017 to 2025. Speaker and faculty fees make up the largest share, 35% of the total. Penumbra, Inc. paid the most, $54,002.

Dr. Kavali graduated from Morehouse School of Medicine in 2010.